Benambax


Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 31.5%
Rheumatoid Arthritis 18.3%
Hiv Infection 7.8%
Pneumocystis Jiroveci Pneumonia 5.0%
Antifungal Prophylaxis 4.6%
Prophylaxis 4.6%
Pneumonia 3.7%
Blood Immunoglobulin G Decreased 2.3%
Hyperlipidaemia 2.3%
Insomnia 2.3%
Reflux Oesophagitis 2.3%
Arthralgia 1.8%
Infection Prophylaxis 1.8%
Osteoporosis Prophylaxis 1.8%
Pericardial Effusion 1.8%
Prophylaxis Against Gastrointestinal Ulcer 1.8%
Stem Cell Transplant 1.8%
Still's Disease Adult Onset 1.8%
Opportunistic Infection Prophylaxis 1.4%
Oral Candidiasis 1.4%
Agranulocytosis 19.4%
Cardiac Failure 12.9%
Pneumocystis Jiroveci Pneumonia 12.9%
Pyrexia 6.5%
Rhabdomyolysis 6.5%
Thrombocytopenia 6.5%
Hyperglycaemia 3.2%
Interstitial Lung Disease 3.2%
Mental Disorder 3.2%
Platelet Count Decreased 3.2%
Pneumocystis Jirovecii Pneumonia 3.2%
Renal Disorder 3.2%
Renal Impairment 3.2%
Sepsis 3.2%
Toxoplasmosis 3.2%
Tracheal Injury 3.2%
White Blood Cell Count Decreased 3.2%
Concomitant
Hiv Infection 20.2%
Prophylaxis 15.0%
Product Used For Unknown Indication 11.5%
Multiple Myeloma 7.7%
Acquired Immunodeficiency Syndrome 4.9%
Interstitial Lung Disease 4.6%
Cytomegalovirus Infection 4.1%
Drug Use For Unknown Indication 3.3%
Immunosuppression 3.2%
Rheumatoid Arthritis 3.1%
Renal Transplant 2.7%
Allogenic Bone Marrow Transplantation Therapy 2.6%
Diabetes Mellitus 2.4%
Antifungal Prophylaxis 2.2%
Disseminated Intravascular Coagulation 2.2%
Infection Prophylaxis 2.2%
Pneumocystis Jirovecii Pneumonia 2.1%
Pneumonia 2.1%
Hypertension 2.0%
Constipation 1.9%
White Blood Cell Count Decreased 18.1%
Platelet Count Decreased 7.4%
Pneumonia 7.4%
Pruritus 6.4%
Sepsis 6.4%
Pneumothorax 5.3%
Tremor 5.3%
Pancreatic Mass 4.3%
Pneumomediastinum 4.3%
Renal Impairment 4.3%
Ureteric Anastomosis Complication 4.3%
Vomiting 4.3%
Liver Disorder 3.2%
Pneumonia Cryptococcal 3.2%
Pyrexia 3.2%
Still's Disease Adult Onset 3.2%
Thrombocytopenia 3.2%
Bone Marrow Disorder 2.1%
Cerebral Haemorrhage 2.1%
Cytomegalovirus Chorioretinitis 2.1%

Drug Data